Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.1M

Reported trades

Filed Stock Type Shares Price Value Since
Dec 17SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 12,04816,666 held (−42%) $41.56 $501K +92.0%
Dec 1SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 20022,714 held (−1%) $42.89 $9K +86.0%
Nov 19SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 64534,539 held (−2%) $40.08 $26K +99.1%
Nov 19SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 11,82522,714 held (−34%) $41.30 $488K +93.2%
Oct 16SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 11,81529,237 held (−29%) $37.65 $445K +111.9%
Oct 16SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 55328,684 held (−2%) $37.99 $21K +110.0%
Oct 1SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 42,00034,552 held (−55%) $38.33 $1.6M +108.1%
  • Sell

    COO Eben Tessari sold $501K of KNSA at $41.56 — cuts the stake by 42%; pre-scheduled 10b5-1 plan sale.

  • Sell

    COO Eben Tessari sold $9K of KNSA at $42.89 — pre-scheduled 10b5-1 plan sale.

  • Sell

    COO Eben Tessari sold $26K of KNSA at $40.08 — pre-scheduled 10b5-1 plan sale.

  • Sell

    COO Eben Tessari sold $488K of KNSA at $41.30 — cuts the stake by 34%; pre-scheduled 10b5-1 plan sale.

  • Sell

    COO Eben Tessari sold $445K of KNSA at $37.65 — cuts the stake by 29%; pre-scheduled 10b5-1 plan sale.

  • Sell

    COO Eben Tessari sold $21K of KNSA at $37.99 — pre-scheduled 10b5-1 plan sale.